| Sign In to gain access to subscriptions and/or personal tools. |
Alveolar Rhabdomyosarcoma With Neuroendocrine/Neuronal Differentiation: Report of 3 CasesDepartment of Histopathology, Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
Department of Pathology, University of Illinois at Chicago, Chicago, Illinois
Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, brian.eyden{at}christie.nhs.uk
Department of Histopathology, Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
Department of Pathology, Royal Albert Edward Infirmary, Wigan, United Kingdom
Department of Diagnostic Molecular Pathology, Royal Manchester Children's Hospital NHS Trust, Pendlebury, United Kingdom
Department of Histopathology, Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
Department of Pathology, University of Illinois at Chicago, Chicago, Illinois
Department of Histopathology, Christie Hospital NHS Foundation Trust, Manchester, United Kingdom The aim of this study is to report the clinicopathologic characteristics of 3 cases of alveolar rhabdomyosarcoma with neuroendocrine/neuronal differentiation. Specimens of 3 cases of alveolar rhabdomyosarcoma were studied using histologic, immunohistochemical, ultrastructural, and molecular genetic techniques. The patients were a 19-year-old man with metastatic alveolar rhabdomyosarcoma in a groin lymph node, a 16-year-old girl with alveolar rhabdomyosarcoma of the perineum, and a 20-year-old man with recurrent orbital alveolar rhabdomyosarcoma. Microscopically, case 1 was composed of compact sheets of medium to large tumor cells. Cases 2 and 3 were small blue round cell tumors. Cases 1 and 3 were solid throughout, whereas case 2 demonstrated alveolar and solid architecture. By immunohistochemistry, the following markers were positive: desmin (3/3), myogenin (3/3), synaptophysin (3/3), and chromogranin (2/3). Ultrastructurally, sarcomeric filaments were seen in all cases, while neuroendocrine granules were detected only in case 1. PAX:FKHR fusion transcript was identified in case 2, case 3 had a variant PAX3 transcript, and case 1 was negative. The data presented expands the known differentiation of alveolar rhabdomyosarcoma.
Key Words: alveolar rhabdomyosarcoma neuroendocrine/neuronal differentiation immunohistochemistry electron microscopy molecular genetics
This version was published on April
1, 2009 International Journal of Surgical Pathology, Vol. 17, No. 2,
135-141 (2009) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

